Pharmacodynamic evaluation for transdermal drugs is critical for understanding how a drug affects the body after being absorbed through the skin. It provides insights into the drug's effectiveness, onset of action, duration of therapeutic effects, and potential side effects. At CD Formulation, our team of experts in pharmacy and pharmacology has developed a comprehensive pharmacodynamic evaluation system tailored to transdermal drugs. This system encompasses studies on dose-response relationships, formulation performance, and mechanisms of action, ensuring a thorough and scientifically robust evaluation. Our services are designed to meet the diverse testing needs of pharmaceutical companies and researchers, offering precise data to guide formulation design and decision-making. By leveraging our advanced methodologies and scientific expertise, we deliver reliable results to support the development of innovative and effective transdermal formulations.
Fig.1 The importance of pharmacodynamic evaluation. (CD Formulation)
Key Parameters | Specific Information |
---|---|
Onset of Action | Time taken for the drug to start showing effects after transdermal application. |
Duration of Effect | How long the drug remains effective after application. |
Peak Effect | The peak effect the drug achieves when applied transdermally. |
Dose-Response Relationship | Evaluating different concentrations to establish the relationship between the dose applied and the pharmacodynamic response. |
We use in vitro skin or artificial membranes to simulate the transdermal process of the formulation under physiological conditions to study the release, transmission amount, and rate of the active ingredients in the topical formulation. This method reflects the clinical effectiveness of the formulation and examines the specific influencing factors of drug transdermal absorption.
After using different animal species through the skin, we collect body fluids (such as blood, urine) or tissues (such as dermis, subcutaneous fat, and subcutaneous muscle tissue) at a set time point, and directly reflect the effectiveness and bioavailability of drug dosage forms by measuring the drug content in the samples. In vivo experiments can obtain the pharmacokinetic parameters and physiological effects of drugs after transdermal absorption and provide a more accurate reference for clinical drug use.
Platform | Specific Information |
---|---|
Instrument platform | High-performance Liquid Chromatograph (HPLC) |
Mass Spectrometer (MS) | |
UV-Vis Spectrophotometer (UV-VIS) | |
Infrared Spectrometer (IR) |
Technology: Transdermal Formulation Pharmacodynamic Evaluation
Journal: Med Devices Sens
IF: 3.9
Published: 2020
Results: A simulation software, SKIN-CAD®, has been developed for the pharmacokinetic-pharmacodynamic (PK-PD) evaluation of TDD. Diffusion models for drug release from matrix devices and drug permeation across the skin can be modeled, in addition to a compartment model for the body elimination and distribution and the pharmacodynamic model. SKIN-CAD® can also analyze the effects of binding and metabolism in the skin, iontophoretic applications, and uptake by dermal blood flow.
The rapid advancement of materials, technologies, and equipment—such as nanotechnology and microneedle technology—continues to drive innovation in transdermal formulation research and development. These cutting-edge technologies enhance transdermal absorption rates, optimize drug formulations, and ultimately improve the therapeutic performance of transdermal drugs. At CD Formulation, we conduct detailed pharmacodynamic studies to evaluate drug efficacy, refine formulation strategies, and provide data-driven insights to support the development of advanced transdermal therapies. For tailored solutions, feel free to contact us. Our team will respond within three business days to address your specific requirements.
References